General Grant. Subject to the terms and conditions of this XXXX, You are hereby granted a limited, royalty-free, non-exclusive right to install and use the SOFTWARE in a manner consistent with its documentation and the license purchased by You.
General Grant. Executive (or an entity or affiliates designated by Executive) shall be granted 10% (calculated with the inclusion of Executive’s stock holdings) of the fully diluted shares of common stock in the Company (the “Stock Grant”) upon conversion of options, warrants and notes in association with a national markets qualified financing as consideration for entering into this Agreement. Such stock shall vest and be delivered to Executive within thirty (30) days following the national markets qualified financing.
General Grant. Executive (or an entity controlled by Executive) shall be granted 20,000,000 shares of common stock in the Company (the “Stock Grant”), valued at the trading price as of the Effective Date, as consideration for entering into this Agreement and remaining an executive for the entire Term. Such stock shall vest and be delivered to Executive on the following schedule, at his direction, but no earlier than the initial one-third (1/3) vesting and deliverable within thirty (30) days following the Effective Date; the second one-third (1/3) vesting and deliverable within thirty (30) days following the one-year anniversary of the Effective Date, and the final one-third (1/3) vesting and deliverable within thirty (30) days following the two-year anniversary of the Effective Date.
General Grant. Subject to Sections 4.1, 4.2, 4.3, and 4.4 hereof, the Common Representative is hereby irrevocably entitled and empowered, on behalf of the Second Priority Indenture Trustee (on its behalf and on behalf of the Second Priority Holders), the Second Priority Collateral Trustee (on its behalf and on behalf of the Second Priority Holders), and the Second Priority Holders, as “recognized creditors” (Acreedores Reconocidos) under the Concursos Law or otherwise, by intervention in any Insolvency or Liquidation Proceeding or otherwise, to exercise any of the Powers granted to or vested in the Common Representative hereunder, including but not limited to (i) taking any and all actions and filing, submitting, or executing any and all documents, releases, instruments, powers of attorney, or other papers that the Common Representative deems necessary or appropriate to exercise the Powers or otherwise comply with the terms of this Agreement, and (ii) instituting and maintaining such suits and proceedings as it may deem appropriate to protect and enforce the Powers granted to and vested in it by this Agreement and proceeding by suit or suits at law or in equity to enforce such Powers under the judgment or decree of a court of competent jurisdiction.
General Grant. Executive (or an entity controlled by Executive) shall be granted 5,129,660 shares of common stock in the Company (the “Stock Grant”), valued at the trading price as of the Effective Date, as consideration for entering into this Agreement and remaining an executive for the entire Term. Such stock shall vest and be delivered to Executive within thirty (30) days following the Effective Date.
General Grant. Executive (or an entity controlled by Executive) shall be granted 20,000,000 shares of common stock in the Company (the “Stock Grant”), valued at the trading price as of the Effective Date, as consideration for entering into this Agreement and remaining an executive for the entire Term. Such stock shall vest and be delivered to Executive on the following schedule, at his direction, but no earlier than the initial one-third (1/3) vesting and deliverable within thirty (30) days following the Effective Date; the second one-third (1/3) vesting and deliverable within thirty (30) days following the one-year anniversary of the Effective Date, and the final one-third (1/3) vesting and deliverable within thirty (30) days following the two-year anniversary of the Effective Date. The Company grants Executive cost free piggyback registration rights for the shares and will use its best efforts to register the underlying shares in a Form S-8 Registration statement, or thereafter in the next registration statement filed by the Company. As of the date of this Amended Agreement, the Company intends to raise money pursuant to a registered offering registered with the United States Securities and Commission (the “SEC”) on Form S-1 (the “Registered Offering”) and to restructure the Company’s debt by entering into warrant and note conversion agreements with all major note holders (the “Debt Restructuring”). The Registered Offering shall be the offering sold pursuant to the first Form S-1 that is filed and becomes effective with the SEC following the date of this Amended Agreement. In addition to all other compensation to the Executive set forth in this Amended Agreement, on the date of the termination of the Registered Offering or upon the culmination of the Debt Restructuring (the “Grant Date”), the Executive shall be issued common shares of the Company so that following the issuance of such shares, the Executive shall own 1.5% of the fully diluted common shares of the Company. To avoid confusion, the calculation of the fully diluted common shares of the Company on the Grant Date shall include without limitation, all shares sold in the Registered Offering including those that may not have been issued as of the Grant Date, all shares required to be issued to other officers of the Company on the Grant Date, all common shares which holders of preferred shares of the Company could legally convert their preferred shares into on the Grant Date, all shares into which outstanding opt...
General Grant. If you obtained the Software and any required Software key(s) from MEDUSYS or one of its authorized Resellers or Distributors and so long as you comply with the terms and conditions of this SSA as a condition to the license granted herein, MEDUSYS hereby grants you a non-exclusive, non-transferable, limited personal license to install and run one copy of the Software in a manner consistent with its design, documentation, and your order. You may only use the Software according to the license ordered by you and granted by MEDUSYS. MEDUSYS offers several license types to meet the needs of its customers’ particular licenses that are offered for the Software depending on the intended use of the Software. Your order shall designate the specific application of the Software which may include, a single user license, a Multi-user License, Site License, Enterprise License, or Volume Discount License, for example.
General Grant. Subject to the terms and conditions of this Agreement, from the date of this Agreement, SBF grants to the CME and CME accepts, a non-exclusive and non-transferable license to: (a) use the Licensed Software (including the source and object codes) and the Licensed Materials for the trading of: (i) CME listed products and for the trading of the products of Approved Exchanges, by Authorized Users; (ii) U.S. Dollar denominated repurchase agreements involving non-European sovereign debt obligations and (iii) such other products not covered by Subsections (i) or (ii) above which CME and SBF may mutually agree upon, in writing, subsequent to the Effective Date hereof; and (b) modify and enhance the Licensed Software. The uses permitted by Subsections (a) and (b) above shall be at the location selected from time to time by the CME and on the hardware configuration designated by the CME. The licenses granted by SBF to CME hereunder shall include the right to permit the operation of the Licensed Software and the Licensed Materials by P.M.T. Limited Partnership (an Illinois limited partnership in which CME is the general partner and CME's members and clearing member firms are limited partners). The CME shall provide SBF with written notice of the locations of the designated hardware configuration used by the CME to operate the Licensed Software. Following the 90 day warranty period described in Article 6, CME may modify the hardware configuration."
General Grant. The District shall grant Association Leave not to exceed an aggregate thirty (30) days to ARs to participate in local, area, regional, state and national Association business. Additional days may be approved by the Superintendent.
General Grant. (a) Licensor hereby grants to Licensee the exclusive right to market and/or distribute and sell, in the Sales Territory (as defined below) and to the Accounts (as hereafter defined) Seller’s current portfolio of consumer products (including Third Party Products and Licensor’s Products) listed on Exhibit F attached hereto (the “Initial Products”), and such other products as shall be added to the list from time to time (such added products, along with the Initial Products, the “Covered Products”), together with the use of all intellectual property associated with Covered Products (including trademarks, patents, copyrights, marketing materials and other collateral materials), all on the terms and conditions set forth in this Agreement and subject, in each instance, to any limitations to any of the foregoing rights as may exist in the Third Party License Agreements or Production and Talent Agreements listed in Exhibit E. Licensee shall be entitled to market, distribute and/or sell the Covered Products on a wholesale basis to (i) national and regional mass, specialty, discount, convenience, drugstore and catalog retailers and chains (including the Seller Accounts), and any other brick and mortar retailer, including sales by retailers through their websites provided shipped to retailers on a bulk basis (Licensee will refer “pick and Pack” orders to Licensor), for resale in the Sales Territory, and (ii) to TK Max in England and Xxxxxxx in Canada (collectively, the “Accounts”); provided that, for the avoidance of doubt, the Accounts shall not include (x) home shopping channels and networks and (y) any limitation on the Accounts existing in the Third Party License Agreements. As used herein, “
